Consilium Evidential KiwiSaver Scheme
Consilium’s Evidentiary KiwiSaver Scheme is a unique offering to the KiwiSaver market, sitting between passively and actively managed Schemes. The Scheme draws on academic research that markets grow over time and the best way to build long term wealth is by spreading investments across different types of assets.
Consilium is a well-established Christchurch based company that delivers a range of investment, portfolio, and planning solutions to financial services firms across New Zealand. It is trusted by over 150 adviser firms and 400 financial advisers, managing NZ$9 billion in assets under advice for more than 20,000 clients.
Consilium have a very experienced investment team including Ben Brinkerhoff, who was previously GM of Bradley Nuttall, COO of Index Funds Advisers in the United States, and has had various Economic Consulting roles in the US and abroad, and Professor Ben Marshall, a leading New Zealand academic on the factors that influence investment returns.
The Scheme focuses on minimising investment fees while aiming for strong performance. The Evidential KiwiSaver Scheme:
- Has a strong focus on diversification, investing across different markets, assets and investment factors, to reduce risk and make members’ investments more resilient to market changes.
- Adheres to an investment approach that draws on academic research that certain investment factors, like size, value and profitability can improve expected returns. It is not about guesswork, like picking winners or trends, but sticking to what investment evidence tells us works.
- Emphasises smart implementation, cost control, global diversification, and tilting portfolios towards these themes to add real value over time
- Understands that many layers go into building a strong portfolio, from asset allocation and factor analysis (statistical analysis to identify meaningful relationships between various assets and their returns), to implementation, fees, tax, and responsible investment filtering.
The Schemes proposition prioritises scientific research, academic insights, and long term financial principles, in contrast to schemes that rely on past performance which can’t be relied on, or low fees which do nothing to add value over time.